Subcellular, sequence-specific detection of RNA in vivo is a powerful tool to study the macromolecular transport that occurs through plasmodesmata. The RNA binding domain of Pumilio proteins can be engineered to bind RNA sequences of choice and fused to fluorescent proteins for RNA imaging. This chapter describes the construction of a Pumilio-based imaging system to track the RNA of Tobacco mosaic virus in vivo, and practical aspects of RNA live-cell imaging.
Introduction
Plasmodesmata serve as intercellular conduits for different species of RNA between plant cells, including siRNAs mediating systemic posttranscriptional silencing (1) , miRNAs involved in developmental control (2) , the infectious genomes of RNA viruses and viroids (3, 4) , and cellular mRNAs (5, 6) . Therefore, techniques which permit the sequence-specific, dynamic localisation of RNAs in live cells are a valuable tool to study plasmodesmata function. A number of such techniques are now available (reviewed in (7, 8) ), but in walled plant cells, non-invasive, genetically encoded reporters are most easily applicable. Such systems use sequence-specific RNA binding proteins (RBPs) fused to fluorescent proteins (FPs), and are best suited to the detection of large RNA species such as viruses and mRNAs. Two classes of RBPs have been employed for generally applicable RNA imaging: bacteriophage-derived peptides that recognise the secondary structure of specific RNA stem-loops (see chapter by Peña in this volume), and the
RNA-binding domain of Pumilio proteins.
Pumilio/FBF family (PUF) proteins are a group of sequence-specific RBPs that are ubiquitous in eukaryotes (26 genes in the Arabidopsis genome) and often function as translational repressors 3 (9) (10) (11) (12) (13) . Their RNA-binding domain, the Pumilio homology domain (PUMHD) has a modular structure consisting of eight tandem repeats of a trihelical, 36 amino acid Puf motif. Each of these Puf repeats binds one nucleotide (Nt) in an eight-Nt binding motif that has no stable secondary structure. All contacts between the PUMHD and RNA are mediated by three amino acid side chains per Puf repeat, and the RNA bases. Amino acid side chains in positions 12 and 16 of each repeat form hydrogen bonds or van der Waals interactions with the Watson-Crickedge of the RNA base whilst the side chain of amino acid 13 forms a stacking interaction (14) .
Because only the interactions at position 12 and 16 are base-specific, the sequence-specificity of the PUMHD can be modified with just two amino acid modifications per repeat to bind to an RNA sequence of choice (14) (15) (16) (17) (18) (19) .
To date, only the PUMHD of human Pumilio1 (HsPUM1-HD) has been used for RNA imaging, but in the future, PUMHDs derived from other PUF proteins may emerge as valuable alternatives and broaden the range of imaging possibilities. Pumilio-based RNA imaging has enabled subcellular detection of the mRNAs of mitochondrial NADH dehydrogenase and -actin, as well as retroviral RNA in mammalian cultured cells (20) (21) (22) (23) , and of the genomes of Tobacco mosaic virus, Potato virus X and Turnip mosaic virus in live plant tissue (24) (25) (26) (27) . Of particular relevance to the topic of this volume, Pumilio-based RNA imaging has recently shown that Potato virus X is present in membrane structures at the entrances of plasmodesmata that also contain the viral replicase (27) .
The advantages of using modified PUMHDs for RNA imaging are 1) untagged, native RNA species expressed from their native genomic context can be localised (20, 21, 24) , avoiding both the need to modify the RNA and to introduce expression constructs into the genome; 2) if instead PUMHD recognition sequences are engineered into an RNA as a tag, no extensive secondary structures are introduced which might affect RNA function and localisation (though the PUMHD can actually access substantially structured target motifs (18) ); 3) PUMHD variants can have 10-to 100-fold higher RNA affinities than stem-loop binding peptides used in alternative RNA imaging systems, thus PUMHD-based imaging is potentially more sensitive.
On the other hand, PUMHD RNA recognition has a degree of promiscuity (28, 29) , and eukaryotic cells contain mRNA targets of native Pumilio proteins. Therefore, all Pumilio-based RNA imaging approaches use two PUMHD variants binding to the same target RNA to increase overall specificity and RNA affinity (20, 30) . In the future, artificial PUMHDs with more than eight repeats that recognise longer target sequences may further improve the specificity of Pumiliobased RNA imaging (18, 30) .
The adjustable sequence specificity of the PUMHD requires re-design and optimisation of Pumilio-based RNA imaging systems for any RNA of interest. Therefore, in the following paragraphs the considerations that have to be made when designing a PUMHD-based reporter system for a new RNA of interest are discussed, before providing a detailed protocol for imaging a specific RNA, that of Tobacco mosaic virus (TMV).
Choice of reporter system
When using any RBP-FP fusion for RNA imaging, it is necessary to distinguish between the RNAbound and free states of the reporter, i.e. RNA-dependent signal and RNA-independent background. For PUMHD-based reporters, three different approaches have been used to identify RNA-bound fluorescence (Fig. 1) . All systems use two PUMHD variants.
Nuclear targeting of a permanently fluorescent pair of fused PUMHDs (Fig. 1A) leads to confinement of fluorescence in the nucleus in the absence of target RNA. If the reporter is coexported from the nucleus with a bound RNA, or binds to cytoplasmic RNA after translation, cytoplasmic fluorescence reveals the RNA's location. This approach is routinely used in RNA imaging with stem-loop binding bacteriophage peptides (see chapter by Peña in this volume).
Attempts to apply the same principle to PUMHD-based imaging with two directly coupled PUMHDs fused to an FP and nuclear localisation signal (NLS) at their N-terminus (NLS-FP-PUMHD-PUMHD) proved unfeasible in plant cells because the reporter aggregated in the nucleus (unpublished data). However, a fusion with the FP inserted between the PUMHDs (NLS-PUMHD-FP-PUMHD) was recently used in mammalian cells (23) and may also work in plants.
Alternatively, the two PUMHD variants can be fused separately to two halves of a split FP, so that when both fusion proteins bind to the same target RNA, the split FP halves come into close proximity and re-fold into the complete FP, resulting in bimolecular fluorescence complementation (PUM-BiFC) at the location of the RNA (20, 24) (Fig 1B) . This principle is the only form of Pumilio-based RNA imaging so far applied in plants ( [24] [25] [26] [27] .
Unfortunately, PUM-BiFC is not background-free. In BiFC, the fluorescent complex of N-and Cterminal split FP halves is extremely stable (31) . As the BiFC constructs accumulate in a cell, the increasing frequency of random collisions will result in the formation of low levels of reassembled FP, independent of interactions of fused PUMHDs with their cognate RNA.
Additionally, due to their stability, PUM-BiFC complexes formed on the target RNA can dissociate from the RNA without 'switching off'. Both of these processes lead to the gradual accumulation of false-positive signal and thus reduce the signal-to-noise ratio. RNA-dependent PUM-BiFC signal has to be distinguished from this background by relative fluorescence levels and localisation (see 3.3.). An additional side-effect of RNA-independent formation of PUM-BiFC complexes is that these pre-formed complexes can be recruited to the target RNA by the interaction of only one of the two PUMHDs. Thus, RNAs can be imaged with only a single binding site (24, 25) or when the orientation of PUMHD fusions would be expected to prevent proximity of split FP halves after RNA binding (see below) (22) . Whilst this may sometimes be useful, it is not generally desirable, as it reduces the overall specificity of the PUM-BiFC system and eliminates the benefits of using two RNA binding domains.
Several recently developed approaches that improve the signal-to-noise ratio of BiFC by introducing further modifications into the split FP fragments (31, 32) are still unexplored for PUM-BiFC applications. Also, a tetramolecular fluorescence complementation system for Pumilio-based RNA detection was recently introduced (PUM-TetFC) (33) (Fig. 1C) which has a very high signal-to-noise ratio in vitro, but is still untested in vivo. In PUM-TetFC, superfolder GFP is split into three fragments, the main -barrel containing -sheets 1-9, and the isolated -sheets 10 and 11, which are fused to the two PUMHD variants (the fourth component of TetFC is the RNA).
In the protocol following below, I describe the construction of a PUM-BiFC system as this is the only Pumilio-based approach so far used successfully in plants. However, as fluorescence complementation techniques are being continuously improved, it is recommended to consult relevant recent literature before constructing a novel PUM-BiFC system.
Choice of FP:
BiFC can be performed with various derivatives of both GFP and red FPs (31, (34) (35) (36) (37) (38) (39) . This allows selection of an FP that will facilitate co-localising the RNA of interest with other fluorescent markers that may already be available. In practice, only the GFP-derivatives EGFP, Venus and mCitrine have so far been used for PUM-BiFC, and of these, only PUMHD-split-mCitrine fusions in plants (20, 24) . PUMHD fusions with split-mRFP1(Q66T) (40) failed to produce fluorescence in preliminary experiments (unpublished data). The PUMHD interacts with RNA in an antiparallel orientation, i.e. the N terminus is oriented towards the 3' and the C terminus towards the 5' end of the target sequence (Fig. 2) . This means that the N terminus of the upstream and the C terminus of the downstream binding PUMHD will be in proximity to each other and have to be fused to the split FP halves. (20, 21, 24, 33 ).
Choice of target sequences and PUMHD variants
PUM-BiFC imaging can be used in two different modes: PUMHDs can be modified to bind to the native RNA of interest (20, 21, (23) (24) (25) , or the RNA can be tagged with recognition motifs of previously characterised PUMHD variants (22, 24, 26, 27, 33) (Table 1) . As described in the introduction, leaving the RNA unmodified has the advantage of avoiding potential RNA processing and localisation artefacts that could be caused by a tag, and by the expression of the tagged construct from an artificial genomic context. The latter is mainly a concern with nuclear mRNAs, not viruses. On the other hand, suitable binding sites that can be easily targeted with a limited number of PUMHD modifications may not be present in the RNA of interest, and whilst the binding specificity of modified PUMHDs can be predicted, it is harder to predict effects of modifications on RNA affinity, binding promiscuity, and protein solubility and stability (15) .
Such potential problems can be avoided by using an RNA tag recognised by previously characterised PUMHD variants ( Table 1) , which can also increase specificity. For instance, Kellermann et al. (33) used a combination of wild-type PUMHD and Mut6-2/7-2 because these bind to their cognate targets with high affinities, but have low affinities for the binding sites of the respective other variant (15) . The choice between modifying PUMHD variants or tagging the RNA will thus depend on considerations of the available target sequences and the suitability of previously characterised PUMHD variants for any given RNA.
Analyse the RNA of interest for the presence of sequences with similarity to native Pumilio binding sites. The target sequence of wild-type HsPUM1-HD is UGUANAUA (N = A, U, or C) (29, 41) (Fig. 2) and most PUMHDs bind to sequences starting with a 5'UGU triplet (29) . This sequence motif is thus a good starting point for the identification of suitable target sequences.
However, PUMHD variants with altered specificity of Puf repeats 6-8 ( Table 1) , which bind to the triplet, have also been used for RNA imaging and detection (20, 24, 33) . Plant RNA virus genomes often contain native Pumilio binding sites that can be exploited for PUM-BiFC imaging (and may be targets of native Pumilio proteins involved in host defense responses) (24, 25, 42, 43) .
The two target sites should be closely adjacent, but separated by a short linker region to prevent steric hindrance of two simultaneously binding PUMHD fusions. With PUM-BiFC, dual target sites separated by linkers between 5 and 11 nucleotides long have been successfully imaged (20- 
22,24) (but see Note 1).
So far, modified PUMHD variants with up to five altered base specificities have been used for RNA imaging (20, 24) , and with up to seven modified Puf repeats in engineered splicing factors (19) . However, with increasing numbers of amino acid changes, effects on overall RNA affinity and protein folding become more unpredictable.
If no suitable binding sites can be identified or very extensive PUMHD modifications would be required, and if no disadvantages from tagging the RNA are expected, select suitable previously described PUMHD variants, e.g. wild-type and mut6-2/7-2 PUMHD (33), to design an RNA tag. In order to not disrupt open reading frames, RNA tags have to be inserted into untranslated regions. A good starting point is to introduce the tag directly downstream of an ORF immediately after the stop codon. Tagging upstream of the start codon may also work, and in some cases, several options may have to be tested (24, 44) . Table 1 lists previously characterised modified PUMHD variants ordered by alterations in their recognition sites from 5' to 3', to facilitate easier selection of RNA target sites or tags. After selection of target sites or tags, the wild-type HsPUM1-HD needs to be modified into two different variants to bind the selected sequences. The molecular code for base-specificity of Puf repeats is as follows (15, 16, 18, 19, 30, 45) : (14, 15) ). The amino acids in position 13, which contribute stacking interactions to RNA binding, are left unchanged (see Note 2). Avoid using Puf4/Nt5 modifications as a main specificity determinant (see Note 3).
Choice of expression system
In principle, PUM-BiFC reporter constructs can be stably expressed, but so far all Pumilio-based RNA imaging in plants has been done with transient expression systems (agroinfiltration or microprojectile bombardment) (24) (25) (26) (27) . Since nonspecific background fluorescence increases with the accumulation of the PUM-BiFC fusions, transient expression may be preferable as it permits limiting background fluorescence by reducing the expression time (see 3.3.).
Agroinfiltration is generally preferable to biolistic bombardment, as it leads to reporter expression in large tissue areas, and makes it easier to assess cell-to-cell variability of PUM-BiFC signal and find optimal imaging conditions (see 3.3.). It is therefore recommended to use agroinfiltration as the first choice of expression system. However, when viral RNAs are imaged, co-expression of agrobacterium-delivered plasmids and virus can be problematic and in that case, bombardment provides a useful alternative means of delivering reporter constructs.
After these general considerations, the following protocol describes the construction of a PUMBiFC system to image the untagged, genomic RNA of Tobacco mosaic virus (TMV) (24, 26 Table 2 ).
Primers (see
4. Standard molecular cloning materials: Commercial kits for high-fidelity PCR amplification, PCR clean up, DNA gel extraction, and plasmid minipreps; PCR machine; gel chamber and power supply for running horizontal agarose gels; benchtop centrifuges; electrocompetent E.coli cells, e.g. strain DH5, and electroporator; LB media (liquid and agar plates) containing either 50 g/ml gentamicin or 100 g/ml spectinomycin; 37C shaking and non-shaking incubators.
Gateway TM vectors pDONR207 (LifeTechnologies) and pGWB402Ω (47).
6. Gateway TM BP and LR Clonase (LifeTechnologies).
7. Electrocompetent Agrobacterium tumefaciens cells, strain AGL1; LB media (liquid and agar plates) containing either 100 g/ml spectinomycin and 50 g/ml rifampicin; 28C shaking and non-shaking incubators.
8. Infiltration medium:10 mM MES pH 5.6, 10 mM MgCl2, 15 M acetosyringone.
9. Spectrophotometer for measuring optical density at 600 nm (OD600).
Gauge 25 needles.
11. 1 ml syringes.
12. 3-4 weeks old Nicotiana benthamiana plants.
13. An infectious clone of TMV which must contain nucleotides 3794-3816 (within the 183k RNA polymerase domain), e.g. TMV.DsRed (24).
14. A commercial kit for RNA in vitro transcription with an RNA polymerase matching the infectious TMV construct (T7 for TMV.DsRed).
15. Aluminium oxide powder. 16 . A confocal laser-scanning microscope equipped with 514 and 561 nm excitation light sources and suitable detection systems for mCitrine and mRFP. An upright microscope equipped with water-dipping lenses is the preferable setup for imaging intact plant tissue in vivo.
Methods

Modification of PUMHDs
To direct one PUMHD variant (PUMHD3794) to bind to the sequence UGUAGAUA (nucleotides 3794-3801 of the TMV genome), the specificity of Puf4 needs to be modified (U5G: N971S/H972N/Q975E). A second PUMHD variant (PUMHD3809) is engineered to bind the sequence UGAUAGUU (nucleotides 3809-3816 of TMV) by altering the specificities of Puf1 (A8U: S863N), 3 (A6G: C935S/Q939E), 4 (U5A: N971C), 5 (A4U: C1007N), and 6 (U3A: N1043C). Fig. 3A for schematic of the construction process and finished fusion construct): PCR#1:Amplify an N-terminal fragment of PUMHD3794 from a wild-type PUMHD template using primer pair link-PUMfor/U5G_441rev (see Table 1 for all primer sequences used in this protocol. All primers are designed for annealing at 55C). Use a proof-reading, high fidelity polymerase according to manufacturer's instructions, but amplify for only 10 cycles to minimize the likelihood of PCR errors. The link-PUMfor primer adds the flexible GGGGS linker that will connect the PUMHD to the N-terminal mCitrine fragment (see below) and a unique XbaI site for easy exchange of PUMHD variants.
PUMHD3794 (see
2. Gel-purify the ~0.4 kb PCR product on a 2% agarose gel using a commercial gel extraction kit. The PCR product will serve as the template in the next PCR reaction and gel purification removes the wild-type PUMHD template that would otherwise be amplified in the next PCR. The multiple mutations introduced in this PUMHD variant require a multi-step overlap PCR. As above, use a high-fidelity polymerase and only 10 PCR cycles for each PUMHD fragment. All PCR products amplified from wild-type template need to be gel-purified before proceeding to subsequent overlap PCR steps.
Construction of PUMHD-split mCitrine fusions
1. Amplify the 0.52 kb N-terminal fragment of Citrine fluorescent protein (CitN; amino acids 1-172) using a plasmid encoding Citrine (e.g. pSAT-Citrine-N1 (46)) as the template, and primers attB-Citfor/link-CitNrev (high-fidelity polymerase, 10 PCR cycles).
The attB-Citfor primers adds a Gateway attB1 anchor, while the link-CitNrev primer adds the GGGGS linker for connection to PUMHD3794.
2. Amplify a C-terminal fragment of Citrine (mCitC; amino acids 173-239) in an overlap PCR that introduces the A206K mutation which prevents dimerization of GFP and its derivatives (48, 49) : Amplify two ~0.1 kb fragments in separate PCRs using primers linkCitCfor/Citmonorev and Citmonofor/attB-Citrev, respectively, from a Citrine-encoding plasmid (high-fidelity polymerase, 10 cycles). The link-CitCfor primer adds the GGGGS linker that will connect to PUMHD3809. The attB-Citrev primer adds a Gateway attB2
anchor. After gel-purification, amplify the complete C-terminal fragment of monomerized Citrine (mCitC) using both partial PCR products as templates, and primers link-CitCfor/attB-Citrev (10 cycles).
3. Amplify the complete CitN-PUMHD3794 fusion using CitN and full-length PUMHD3794 PCR products as templates, and primers attB1-adapter/attB2-adapter. Use a high-fidelity polymerase and 20 PCR cycles. Run a 5 l aliquot of the PCR reaction on a 1% agarose gel. If there is a single, 1.6 kb product, remove remnants of the PCR reaction using a commercial PCR clean up kit. If more than one PCR product was obtained, run the rest of the PCR out on the gel, and excise and gel-purify the 1.6 kb band using a commercial kit. 4 . Amplify the complete PUMHD3809-mCitC fusion using full-length PUMHD3809 and mCitC PCR products as templates, and primers attB1-adapter/attB2-adapter. Use a highfidelity polymerase and 20 PCR cycles. Run a 5 l aliquot of the PCR reaction on a 1% agarose gel. If there is a single, 1.3 kb product, remove remnants of the PCR reaction using a commercial PCR clean up kit. If more than one PCR product was obtained, run the rest of the PCR out on the gel, and excise and gel-purify the 1.3 kb band using a commercial kit.
Recombine both CitN-PUMHD3795 and PUMHD3809-mCitC products into a Gateway
DONR vector, e.g. pDONR207 (Gent R ), using Gateway TM BP recombinase (LifeTechnologies) according to manufacturer's instructions. Transform the BP recombination into E.coli competent cells and plate on LB agar containing 50 g/ml gentamicin. On the next day, pick several colonies for overnight culture in LB liquid media containing gentamicin, then isolate the plasmids using a commercial kit. Verify that the mCitN-PUMHD3794 and PUMHD3809-CitC fusions have no PCR errors by sequencing the DONR vector inserts.
6. Recombine error-free fusion constructs into a Gateway destination binary vector for plant expression, e.g. pGWB402Ω (Spec R ; (46)), using Gateway TM LR Clonase (LifeTechnologies) according to manufacturer's instructions. Transform the LR reaction into E. coli competent cells and plate on LB agar containing 100 g/ml spectinomycin. On the next day, pick several colonies for overnight culture in LB liquid media containing spectinomycin, then isolate the plasmids using a commercial kit. Check that correct expression constructs were obtained by diagnostic restriction digest (e.g. excising the ~1.05 kb PUMHD using XbaI/XhoI).
PUM-BiFC in vivo imaging
1. Transform CitN-PUMHD3794 and PUMHD3809-mCitC binary expression vectors separately into electrocompetent Agrobacterium tumefaciens cells strain AGL1 (other strains are also suitable). Plate the transformed agrobacteria on LB agar containing 100 g/ml spectinomycin to select for transformants, and 50 g/ml rifampicin to suppress growth of other bacteria. Grow plates at 28C for two days. 3. Two days after infection, pick single colonies into 4 ml liquid LB media containing spectinomycin and rifampicin and grow in a shaking incubator at 28C for two days (see
Note 5).
4. Pellet the bacterial cultures, then resuspend each pellet into 2 ml infiltration medium.
5. Incubate the resuspended agrobacteria at room temperature in the dark for about 1 h, then measure the OD600.
6. Mix and dilute CitN-PUMHD3794 and PUMHD3809-mCitC-containing agrobacteria with infiltration medium so that both are present at OD600 = 0.25 in the final mixture (i.e. total combined OD600 = 0.5).
With the tip of a needle, create small incisions on the abaxial (lower) side of uninfected
and TMV-infected Nicotiana benthamina leaves by gently touching the leaf surface with the needle so that a dark point is just visible.
8. Carefully infiltrate the agrobacterium mixture into these incisions using a 1 ml syringe without a needle pressed on the incision site (see Note 6). Ca. 1-2 ml of suspension are required to cover a leaf. Agrobacteria can be infiltrated in patches, e.g. overlapping with virus-infected issue areas, or into the entire leaf lamina, depending on experimental requirements.
9. For imaging, place whole or half leaves or ~2 x 2 cm leaf pieces under a microscope lens by fixing them to a microscope slide using double-sided sticky tape, with the lower epidermis facing up. An upright microscope with water-dipping lenses, which can be directly immersed in a drop of water placed on the leaf with no cover glass in between, is ideal for plant imaging. Excite mCitrine BiFC at 514 nm and detect mCitrine fluorescence at 520-550 nm. Excite DsRed at 561 nm and detect DsRed fluorescence at 570-600 nm. and also a re-localisation. In particular, nucleoplasmic signal usually disappears in the presence of target RNA and instead of general cytoplasmic fluorescence, the PUM-BiFC signal is expected to be concentrated in granular viral replication sites which can be small and dispersed in the cytoplasm, or aggregated into a large perinuclear inclusion body (24, 25) (Fig. 4) . 2. Amino acid residues that participate in stacking interactions with the RNA bases can also contribute to base specificity, and their modification can either increase or decrease binding promiscuity (19, 50) . However, modifying these residues can also negatively affect overall RNA affinity and protein solubility (15, 50) . Therefore, until a systematic investigation has led to a detailed understanding of stacking interactions in HsPUM1-HD, it is recommended that amino acids at position 13 of the Puf repeats are not modified. 6. Young leaves are easier to infiltrate as they have larger airspaces. Avoid pressing the opening on the syringe too hard onto the leaf surface as this will cause extensive damage.
Monitoring BiFC for several days after infiltration
Also, if air spaces in the mesophyll are tight causing a high resistance to the infiltration, increasing the injection pressure is more likely to cause agrobacterium mixture to squirt out sideways from under the rim of the syringe than to improve infiltration.
7. Since folding and stability of split FP fragments are influenced by fusion partners such as the PUMHD variants (which may themselves differ in their respective in vivo folding efficiency and stability), unfused split FP halves are no suitable negative control in BiFC.
Ideal BiFC controls are fusions with non-interacting variants of the proteins used in the actual experiments (31) . In the case of PUM-BiFC this corresponds to either the absence of the target RNA as described here, or PUMHD fusions that do not bind the target RNA (24, 33) . Background fluorescence due to random collisions should be the same for both types of controls. However, the ability to bind cellular RNAs promiscuously, as well as the folding efficiency and stability of the PUMHD-split FP fusions may differ for different pairs of PUMHDs. Therefore, expressing the target RNA-specific reporter constructs in the absence of the target provides the best negative control. 10. PUM-BiFC expression levels may need to be re-optimised when imaging different infection stages. In strongly infected tissue at late infection stages, expression of the RNA reporter constructs may be too strongly suppressed to produce sufficient PUM-BiFC signal for imaging. Conversely at early infection stages, if PUM-BiFC accumulates too much compared to viral RNA levels, the signal-to-noise ratio will be too low to clearly localise the viral RNA over the background.
To compensate for such effects, PUMHD fusion constructs can be agroinfiltrated at an OD600 between ~0.1 and 1.0 each (at a 1:1 ratio). It may also be worth experimenting with unequal expression ratios to optimise the signal-to-noise ratio and minimize aggregation (24) . 
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